- Home
- BKYI vs EYEN Comparison
BKYI vs EYEN Comparison
Compare BKYI & EYEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKYI
- EYEN
- Stock Information
- Founded
- BKYI 1993
- EYEN 2014
- Country
- BKYI United States
- EYEN United States
- Employees
- BKYI N/A
- EYEN N/A
- Industry
- BKYI Computer Software: Prepackaged Software
- EYEN Biotechnology: Pharmaceutical Preparations
- Sector
- BKYI Technology
- EYEN Health Care
- Exchange
- BKYI Nasdaq
- EYEN Nasdaq
- Market Cap
- BKYI 3.8M
- EYEN 3.7M
- IPO Year
- BKYI 1997
- EYEN 2018
- Fundamental
- Price
- BKYI $0.75
- EYEN $1.18
- Analyst Decision
- BKYI
- EYEN Hold
- Analyst Count
- BKYI 0
- EYEN 4
- Target Price
- BKYI N/A
- EYEN $2.00
- AVG Volume (30 Days)
- BKYI 391.9K
- EYEN 495.7K
- Earning Date
- BKYI 03-27-2025
- EYEN 05-14-2025
- Dividend Yield
- BKYI N/A
- EYEN N/A
- EPS Growth
- BKYI N/A
- EYEN N/A
- EPS
- BKYI N/A
- EYEN N/A
- Revenue
- BKYI $6,929,571.00
- EYEN $31,832.00
- Revenue This Year
- BKYI $1.96
- EYEN $23,413.60
- Revenue Next Year
- BKYI $9.65
- EYEN $400.98
- P/E Ratio
- BKYI N/A
- EYEN N/A
- Revenue Growth
- BKYI N/A
- EYEN 2557.09
- 52 Week Low
- BKYI $0.52
- EYEN $1.06
- 52 Week High
- BKYI $3.68
- EYEN $124.80
- Technical
- Relative Strength Index (RSI)
- BKYI 30.45
- EYEN 26.42
- Support Level
- BKYI $0.75
- EYEN $1.06
- Resistance Level
- BKYI $1.20
- EYEN $1.76
- Average True Range (ATR)
- BKYI 0.11
- EYEN 0.10
- MACD
- BKYI -0.03
- EYEN 0.05
- Stochastic Oscillator
- BKYI 7.92
- EYEN 10.51
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.